Related Experiment Video
Updated: May 21, 2026
11:20
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
Published on: March 21, 2018
Cancers of unknown primary site
Mehar Aziz1, Nishat Afroz, Ashutosh Awasthi
1Department of Pathology, JN Medical College, Aligarh Muslim University, Aligarh 202002.
Journal of the Indian Medical Association
|June 7, 2012
Summary
Tumours of unknown primary origin are cancers detected at metastatic sites without a known primary tumor. This review highlights their unique biological behavior and genetic characteristics, posing diagnostic and therapeutic challenges.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Carcinoma of unknown primary origin (CUP) accounts for 3-15% of all cancers.
- CUP presents a significant diagnostic and therapeutic challenge due to the inability to identify the primary tumor site.
- Hallmarks include primary tumor dormancy, early systemic metastases, and therapy resistance.
Purpose of the Study:
- To review the biological behavior of unknown primary tumors.
- To highlight the genetic aberrations associated with unknown primary tumors.
- To discuss the ongoing debate on whether CUP represents a distinct entity or a group of metastatic primaries.
Main Methods:
- Literature review of existing studies on carcinoma of unknown primary origin.
- Analysis of biological behaviors and genetic profiles of CUP.
- Synthesis of current understanding and controversies in the field.
Main Results:
- Unknown primary tumors exhibit unique biological characteristics, including potential primary tumor regression or dormancy.
- Genetic aberrations in CUP are being increasingly identified.
- The heterogeneity of CUP complicates classification and treatment strategies.
Conclusions:
- Carcinoma of unknown primary origin is a complex clinical entity with distinct biological and genetic features.
- Further research is needed to determine if CUP is a unique disease entity or a subset of metastatic cancers.
- Understanding the biology and genetics of CUP is crucial for developing targeted therapies.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.